← Leaderboards
Nina Beth Gold
Massachusetts General Hospital
$2,729,558
Attributed
$15,071,895
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $14.6M · FY2023–25$20M$15M$10M$5M$0
'23
'24
'25
Funding mix
By agency
NIH$15,071,895 · 2
By mechanism
OT2$14,399,393 · 1
K08$672,502 · 1
Top collaborators
- Robert C. Green1 shared
- Ingrid Adele Holm1 shared
- Nicole R Kelly1 shared
- Stuart R. Lipsitz1 shared
- Jelili Ojodu1 shared
- Melissa Pittel Wasserstein1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Michael A Moskowitz$13,795,692
- Schahram Akbarian$48,610,378
- Cenk Ayata$15,872,648
- Brian J Bacskai$26,389,294
- Matthias Nahrendorf$28,669,447
Others in their field
Other Rising Stars on “Genomics”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Gary Mays · Axle Informatics, Llc$58,129,860
- Mari Ostendorf · University Of Washington$51,931,230
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Bridget Murphy · Broad Institute, Inc.$23,600,775
- Michelle Rives · Baylor College Of Medicine$20,650,593
Research focus
GenomicsPublic HealthGenesGenomic DataMedicalProgramsFollow-UpFutureGenetic VariantGenome SequencingInfantEconomic OutcomeNeonatal ScreeningPersonsAwardDiagnosticBehavioral OutcomeFoundationsGenetic DiseasesGenetic RiskGenomeDesignHospitalsScreening
Grant awards (4)
Feasibility of Genomic Newborn Screening Through Public Health Laboratories$14,399,393
OT2 · FY2025 · OD
Genome-first approach to treatable genetic conditions in adults$232,870
K08 · FY2025 · HG · contact PI
Genome-first approach to treatable genetic conditions in adults$227,362
K08 · FY2024 · HG · contact PI
Genome-first approach to treatable genetic conditions in adults$212,270
K08 · FY2023 · HG · contact PI